CANNAPHARMARX, INC. Operating Income Loss

• CANNAPHARMARX, INC. showed an increase of +7.8% in Operating Income Loss from 2024 to 2025.
• This data is from CANNAPHARMARX, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), CANNAPHARMARX, INC.'s Operating Income Loss has declined by 671.7%.
• Historical annual values: Fiscal year 2025: -$3.35 million | Fiscal year 2024: -$3.63 million | Fiscal year 2023: -$1.58 million | Fiscal year 2022: -$5.21 million | Fiscal year 2021: -$2.99 million | Fiscal year 2020: -$14.49 million | Fiscal year 2019: -$15.98 million | Fiscal year 2018: -$954.3 thousand | Fiscal year 2017: -$6.6 thousand | Fiscal year 2016: -$1.00 million | Fiscal year 2015: -$11.65 million | Fiscal year 2014: -$3.97 million | Fiscal year 2013: -$80.3 thousand | Fiscal year 2012: -$89.6 thousand | Fiscal year 2011: -$97.1 thousand | Fiscal year 2010: $585.6 thousand.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026